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Abstract: Adenylate kinase and downstream AMP signaling is an integrated metabolic 
monitoring system which reads the cellular energy state in order to tune and report signals 
to metabolic sensors. A network of adenylate kinase isoforms (AK1-AK7) are distributed 
throughout intracellular compartments, interstitial space and body fluids to regulate 
energetic and metabolic signaling circuits, securing efficient cell energy economy, signal 
communication and stress response. The dynamics of adenylate kinase-catalyzed 
phosphotransfer regulates multiple intracellular and extracellular energy-dependent and 
nucleotide signaling processes, including excitation-contraction coupling, hormone 
secretion, cell and ciliary motility, nuclear transport, energetics of cell cycle, DNA 
synthesis and repair, and developmental programming. Metabolomic analyses indicate that 
cellular, interstitial and blood AMP levels are potential metabolic signals associated with 
vital functions including body energy sensing, sleep, hibernation and food intake. Either 
low or excess AMP signaling has been linked to human disease such as diabetes, obesity 
and hypertrophic cardiomyopathy. Recent studies indicate that derangements in adenylate 
kinase-mediated energetic signaling due to mutations in AK1, AK2 or AK7 isoforms are 
associated with hemolytic anemia, reticular dysgenesis and ciliary dyskinesia. Moreover, 
hormonal, food and antidiabetic drug actions are frequently coupled to alterations of 
cellular AMP levels and associated signaling. Thus, by monitoring energy state and 
generating and distributing AMP metabolic signals adenylate kinase represents a unique 
hub within the cellular homeostatic network. 
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1. Introduction 
Recent studies provide new evidence of the unique energetic, metabolic monitoring and signaling 
role played by the ubiquitous enzyme adenylate kinase which catalyzes the nucleotide phosphoryl 
exchange reaction 2ADP ↔ ATP + AMP, critical in cell life [1-11]. Historically, the function of 
adenylate kinase has been ascribed to de novo adenine nucleotide synthesis and cell energy economy 
through regulation of nucleotide ratios in different intracellular compartments and AMP-sensitive 
metabolic enzymes [1,12-17]. Adenylate kinase has been intensely studied, including its genetics and 
gene polymorphism, tissue and developmental expression, intracellular distribution and structure-
function relationship [2,3,14,16-25]. This exemplifies adenylate kinase as a model protein for 
nucleotide binding folds and phosphoryl transfer catalysis [19,24,25]. The energetic role of adenylate 
kinase has gained particular significance following discovery that this enzyme facilitates transfer and 
utilization of γ- and β-phosphoryls in the ATP molecule through a chain of sequential reactions [1,26-
28]. The adenylate kinase-catalyzed energy transfer shuttle and ligand conduction circuit concept 
[1,5,29-31] (Figure 1) is supported by biochemical, phosphoryl exchange measurements using 
18O-
labeling, physiological and gene-knockout studies [4,5,8,15,27-42], and is broadly used to explain 
energetic signaling mechanisms in heart and skeletal muscles [5,15,42-44], in hormone secretion [45-
47], organ failure [4,31,48-50], tumor development [51-53], energy support of the cell nucleus 
[30,34,54,55], as well as in sperm and cell motility [8,56-59]. Muscles of AK1 knockout mice, with 
one less phosphotransfer chain, display lower energetic efficiency, slower relaxation kinetics and a Int. J. Mol. Sci. 2009, 10                 
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faster drop in contractility upon ischemia associated with compromised myocardial-vascular crosstalk, 
AMP and adenosine generation, and impaired metabolic signal communication to the membrane 
metabolic sensor - the ATP-sensitive potassium channel (K-ATP) and distorted signaling to the 
energy-sensing AMP-activated protein kinase (AMPK) [4,5,1,32,33,35,39-42]. The unique ability of 
the 
18O-assisted 
31P-NMR technique to monitor adenylate kinase phosphotransfer and AMP signal 
dynamics in intact tissues, together with measurements of phosphotransfer rates through creatine 
kinase and glycolytic/glycogenolytic circuits and responses of metabolic sensors provide further 
insights into an integrated cellular energetic, metabolic monitoring and energy sensing interface 
[5,30,37,44,60]. 
Figure 1. Adenylate kinase shuttle facilitates transfer of ATP β- and γ-phosphoryls from 
generation to utilization sites. 
 
Adenylate kinase (AK), present in mitochondrial and myofibrillar compartments, enables the 
transfer and makes available the energy of two high-energy phosphoryls, the β- and the γ-
phosphoryls of a single ATP molecule. In this case, AMP signals feedback to mitochondrial 
respiration amplified by the generation of two molecules of ADP at the mitochondrial 
intermembrane site. Within the intracellular environment of a cardiomyocyte, the transfer of ATP 
and AMP between ATP-production and ATP-consumption sites may involve multiple, sequential, 
phosphotransfer relays that result in a flux wave propagation along clusters of adenylate kinase 
molecules (lower panel). Handling of substrates by “bucket-brigade” or a ligand conduction 
mechanism facilitates metabolic flux without apparent changes in metabolite concentrations. AK1 
and AK2 – cytosolic and mitochondrial AK isoforms, respectively. i.m. and o.m. – inner and outer 
membranes, respectively. Modified from [5] with permission. 
 
Due to a unique property of the catalyzed reaction, adenylate kinase is recognized as a sensitive 
reporter of the cellular energy state, translating small changes in the balance between ATP and ADP 
into relatively large changes in AMP concentration [1,2,5,29,62]. This enables enzymes and metabolic 
sensors that are affected by AMP to respond with higher sensitivity and fidelity to stress signals 
[33,35,42,52,60-63]. Recent data further indicate that adenylate kinase mediated intracellular AMP Int. J. Mol. Sci. 2009, 10                 
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signaling is coupled with a number of AMP-responsive elements including metabolic sensors, AMP-
sensitive metabolic enzymes and adenosine signaling [5,30,33,42,47,61-65]. By catalyzing nucleotide 
exchange and AMP signaling, adenylate kinase regulates the activity of glycolytic and glycogenolytic 
enzymes and provides an integrative node for both pathways to respond rapidly to fluctuating energy 
demands [5,30]. Adenylate kinase generated AMP is emerging as a potential metabolic signal whose 
intracellular and circulatory levels determine the balance of peripheral organ energy supply between 
glucose, glycogen and fat, thus regulating food intake, hormonal state, sleep, hibernation and body 
energy sensing in conjunction with hypothalamic AMP-activated protein kinase (AMPK), K-ATP 
channels and adenosine metabolic signaling cascades [4,5,30,63-69]. Thus, such integrated energetic 
and metabolic signaling roles place adenylate kinase as a hub within the metabolic regulatory system 
coordinating components of the cellular bioenergetics network. 
A distinct role for adenylate kinase is emerging in cell motility, differentiation and mechano-
electrical signal transduction. Adenylate kinase has been implicated in spermatozoa motility by 
facilitating ATP delivery from midpiece mitochondria to remote ATPases in the tail [20]. It was 
demonstrated that through interaction with anchoring protein Oda5p adenylate kinase provides local 
ATP for dynein ATPase, ensuring that both high-energy phosphate bonds of ATP are efficiently 
utilized at the major site of power production of the microtubule motors involved in diverse cellular 
movements [57,70]. A recent study has demonstrated that a mutation in adenylate kinase 7 (AK7) 
underlies a primary ciliary dyskinesia phenotype in chronic obstructive pulmonary disease [7]. 
Moreover, van Horssen et al. [8] demonstrated that cytoskeleton-based cell motility can be modulated 
by spatial repositioning of adenylate kinase 1 (AK1) enzymatic activity providing local ATP supply 
and 'on-site' fueling of the actomyosin-machinery. More significantly and unexpectedly, mutations in 
the mitochondrial AK2 (adenylate kinase 2) gene have been identified in individuals affected with 
reticular dysgenesis, the most severe form of inborn severe combined immunodeficiencies (SCID), 
which is associated with sensorineural deafness, a process where nucleotide signaling, cell motility and 
ciliary functions are involved [9,10]. Knockdown of zebra fish ak2 lead to aberrant leukocyte 
development, stressing the critical role of AK2, the major isoform in this type of cells, in leukocyte 
differentiation [10].  
It is increasingly recognized that systemic integration of complementary energetic and metabolic 
signaling networks ensures cellular energy homeostasis and an adequate response to a broad range of 
functional activities and stress challenges [5,44]. A network and circuit view of the cellular energetic 
system allows for new perspectives leading to a comprehensive understanding of disease conditions 
associated with disturbances in energy metabolism, metabolic monitoring and signaling, and metabolic 
sensors response [5,71,72]. The purpose of this review is to summarize recent evidence regarding the 
role of the adenylate kinase phosphotransfer circuit in facilitating intracellular energetic 
communication, metabolic monitoring and AMP signal transduction. We highlight that due to intrinsic 
catalytic properties adenylate kinase is able to monitor and sense cell and body energetic imbalances 
caused by physical activity, inadequate oxygenation or nutrient supply. By generating and transmitting 
metabolic signals to a number of AMP/nucleotide-sensitive cellular and extracellular components, 
adenylate kinase is a primary player in adjusting cellular energetics, food intake, substrate transport 
and vascular blood flow to direct nutrient and oxygen delivery and maintain energy homeostasis. Int. J. Mol. Sci. 2009, 10                 
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2. Adenylate Kinase Isoform-Based Energetic and Metabolic Signaling Network 
The existence of multiple isoforms of an  enzyme usually relates to their different intracellular 
distribution and kinetic properties according to the local metabolic requirements (Figure 2) 
[8,13,14,51,56,57,73]. Following the discovery of adenylate kinase more than six decades ago [see 
57], three major isoforms, AK1, AK2 and AK3 have been identified, which are localized in the 
cytosol, mitochondrial intermembrane space and matrix, respectively [13,14,73]. They differ in 
molecular weight, structure, kinetic properties and nucleotide specificity [19,25,74]. AK1 and AK2 
specifically bind AMP and favor binding to ATP over other nucleotide triphosphates, while AK3 is a 
GTP:AMP phosphotransferase specific for the phosphorylation of intramitochondrial AMP, but can 
only use GTP or ITP as a substrate [13,75]. Within the AK family there are several conserved regions, 
including a P-loop, AMP- and MgATP/MgADP-binding domains and a lid domain [19,25]. Adenylate 
kinase isoforms can form dimers and higher molecular order structures [76,77]. Phosphorylation of 
adenylate kinase has not been detected; but acetylation and myristoylation, which could facilitate 
binding of adenylate kinase to cell membranes, mitochondria or the nucleus, have been demonstrated 
[56,73,78]. Recently discovered glutathionylation of adenylate kinase could confer regulation of its 
activity by the cellular redox state [79]. 
Figure 2. Adenylate kinase isoform network and intracellular localization. 
 
 
Adenylate kinase isoforms are coded by separate genes, KAD1 – KAD7, localized to different 
chromosomes. Corresponding proteins AK1 – AK7 define separate adenylate kinase isoforms with 
different molecular weights, kinetic properties and intracellular localization. The AK1 isoform 
mostly consists of the ADK domain which is characteristic for the whole protein family. The AK1β 
splice variant has an additional myristoylation domain that targets the protein to the plasma 
membrane. The proteins Rad50 and C9orf98 with ADK domains and activity have specific cellular 
functions. The AK2, AK3 and AK4 isoforms have a flexible lid domain which closes over the site 
of phosphoryl transfer upon ATP binding to prevent water accessibility. A short form of the lid 
domain exists also in AK1, AK5 and AK6. Within the network adenylate kinase proteins distribute 
high-energy phosphoryls (~ P) and communicate AMP signals. 
 Int. J. Mol. Sci. 2009, 10                 
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Different polymorphic subforms of AK1 (AK1-1 and AK1-2) and splice variants of AK2 (AK2A-
D) have been found, which have distinct electrophoretic mobility and kinetic properties, i.e. AK2A 
(26.5 kDa) and AK2B (25.6 kDa) [2,5,80,81]. AK1-2 occurs only in the Caucasian populations and is 
common among hemophilia-A patients [81]. A recent study indicates that the negative effect of smoke 
on birth weight is more marked in AK1-1 mothers that in AK1-2 carriers, suggesting that zygotes 
carrying AK1-2 allele are more protected from damaging factors [82]. Interestingly, the specific 
activity of AK1-2 is about 3.5-times lower than that of AK1-1, whereas the Michaelis constants do not 
differ for the allelozymes [80]. Sequence analysis showed that Glu-123 in AK1-1 is exchanged for 
Gln-123 in AK1-2. Mitochondrial AK2-1(A) subform was found in about 30% of bipolar manic 
depression syndrome (MDS) patients, but in no case of unipolar MDS or controls. Also, tissue specific 
adenylate kinase isoforms AK4 and AK5 have been cloned which have mitochondrial matrix and 
cytosolic localization respectively (Figure 2) [2,23]. AK4 protein levels are increased in cultured cells 
exposed to hypoxia and in animal models of neurodegenerative diseases [83]. Although AK4 is 
enzymatically inactive it retains nucleotide binding capability, interacts with the mitochondrial 
ADP/ATP translocator and serves stress responsive protein function promoting cell survival and 
proliferation [83]. Both AK4 and AK3 are among hypoxia-inducible factor 1 (HIF-1) regulated genes 
promoting cell survival [84,85]. AK5 was detected in human pancreatic beta-cells and was implicated 
in regulation of the K-ATP channel [47], while appearance of autoantibodies to AK5 in refractory 
limbic encephalitis patients carries a poor prognosis [86]. More recently, the existence of an additional 
AK1 gene product, the p53-inducible membrane-bound myristoylated AK1β, has been reported and 
implicated in p53-dependent cell-cycle arrest and nucleotide exchange in the submembrane space 
[51,73,87]. In this context, the gene encoding AK1 is down-regulated during tumor development, 
which could be associated with lower AK1β levels and cell cycle disturbances [88]. AK1β also has 
been demonstrated to be associated with the nuclear envelope [73] and proteomic studies have 
identified AK1β in epithelium microvilli [89], suggesting a role in energy support of nuclear and 
epithelia transport processes. 
2.1. Adenylate kinase isoforms in the nucleus 
The AK6 isoform was identified to be localized to the cell nucleus where energy provision and 
nucleotide channeling into DNA synthesis play a critical role in processing genetic information 
[34,54]. However, there is still controversy regarding the AK6 isoform which is also known as TAF9 
RNA polymerase II possessing ATPase activity [90], suggesting that other adenylate kinase isoforms 
(AK1 and AK5) can also subserve nuclear energetic needs (Figure 2) [13,34,73]. Knockdown of AK6 
slows growth and development of C. elegans [91], while in yeast a point mutation in Fap7 gene, an 
analog of AK6, reduces growth on glucose [92]. Another nuclear protein Rad50, a member of DNA 
repair RAD50/MRE11/NBS1 protein complex (RMN), which is essential for sensing and signaling 
from DNA double-strand breaks, in addition to ATP binding and hydrolysis bears an adenylate kinase 
activity required for efficient tethering between different DNA molecules [93]. A mutation affecting 
the adenylate kinase activity of Rad50, necessary for DNA tethering also abolishes the formation of 
viable spores [93]. Mutations in the genes that encode Nbs1 and Mre11, which are part of the RMN 
complex, are responsible for the human radiation sensitivity disorder, the Nijmegen breakage Int. J. Mol. Sci. 2009, 10                 
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syndrome (NBS), and the ataxia-telangiectasia-like disorder (ATLD), which are characterized by 
defective checkpoint responses and high levels of chromosomal abnormalities [94]. Interestingly, the 
Nijmegen breakage syndrome gene product, Nbs1, is required for enzymatic activities of Rad50 and 
whole RMN complex function, including partial unwinding of a DNA duplex and efficient cleavage of 
fully paired hairpins [95]. Thus, adenylate kinase and adenylate kinase activity-possessing proteins 
play a significant role in the energetics of cell nucleus which is separated from major ATP generating 
processes in the cytosol. 
2.2. Adenylate kinase isoforms in cell motility and nucleotide pool homeostasis 
The large molecular weight isoform AK7 is associated with cell motility and other processes [5]. 
Recently, a high level of expression of the AK7 isoform has been demonstrated in bronchial 
epithelium and appears to be associated with ciliary function [96]. AK7 is a differentiation marker of 
kinocilia-bearing cells [97], and mutation in the AK7 gene is associated with human ciliary dyskinesia 
[7]. In this regard, Foxj1, a forkhead transcription factor necessary for ciliogenesis, induces adenylate 
kinase isoforms AK5 and AK7 along with genes whose products comprise dynein arms [98]. Yet to be 
named, a protein with adenylate kinase domains coded by chromosome 9 open reading frame 98 
(C9orf98) gene is associated with cell migration and nucleotide exchange [99]. In this regard, sea 
urchin embryo cilia and sperm flagella use high-molecular weight adenylate kinase with triplicated 
catalytic domains to power swim by ciliary and flagellar movement [100]. Thus, multiple adenylate 
kinase isoforms create a phosphotransfer network to serve specific needs in different cellular 
compartments for energetic and metabolic signaling. 
Heart muscle harbors about 30 – 40% of adenylate kinase activity in mitochondria particularly in 
the intermembrane space [26,74]. The mitochondrial AK2 isoform has the highest affinity (lowest Km) 
for AMP (≤ 10 μM) among AMP metabolizing enzymes and is highly concentrated in the narrow 
intermembrane space [18,26,74]. Virtually all the AMP reaching mitochondria is converted to ADP 
and channeled into oxidative phosphorylation maintaining a low cytosolic AMP concentration 
[21,35,41,101]. In such a way, adenylate kinase tunes cytosolic AMP signals and guards the cellular 
adenine nucleotide pool [1,41,102,103]. During intense physical activity or metabolic stress, such as 
ischemia, the AMP concentration rises, turning on other AMP-metabolizing enzymes such as AMP-
deaminase and 5’-nucleotidase producing IMP and adenosine [60,104]. In this regard, a marked 
elevation of mitochondrial AK2 activity has been demonstrated in hypertrophy in response to 
increased energy demand and the necessity to maintain the cellular adenine nucleotide pool [105]. In 
Drosophila, AK2 is essential for survival and circadian rhythm formation and the lack of the AK2 gene 
causes significant insect growth suppression [2]. AK2 is downregulated in Keloids disease associated 
with fibroproliferative dermal tumors developing as a result of deregulated wound healing [106]. 
Expression of adenylate kinase isoforms increases in response to muscle exercise, hypoxia, and 
metabolic stress [107,108]. Also, muscle exercise performance correlates with adenylate kinase 
activity, signifying that this enzyme is an integral part of cellular energetic homeostasis [108]. In 
addition, a decreased expression and activity of AK1 has been found in a mouse model for muscular 
dystrophy (mdx mice) suggesting a direct relationship between lack of dystrophin and alteration of Int. J. Mol. Sci. 2009, 10                 
 
 
1736
AK1 inducing energetic deficit [109]. A significant increase in AK1 in obese patients could indicate an 
imbalance in AMP signaling in this metabolic syndrome [110]. 
2.3. Adenylate kinase localization and interacting partners 
Although major compartments for adenylate kinase isoform localization are known based on 
cellular fractionation, intimate intracellular anatomy of adenylate kinase distribution has only been 
studied by immunocytochemistry in neuronal cells and skeletal muscle [74,111,112]. In skeletal 
muscle myofibrils, adenylate kinase is localized in linear arrays along with creatine kinase and 
glycolytic enzymes [111]. Similar localization of GFP-tagged AK1 was detected in neonatal 
cardiomyocytes [76]. Such sequential arrangement of adenylate kinase molecules could provide a 
bidirectional phosphorelay that links ATP-generation with ATP-consumption and ATP-sensing 
processes [1,5]. Another study using tagged proteins indicates that AK1β-EGFP is mainly localized on 
the plasma membrane, whereas AK1-EGFP is distributed throughout the cell except for trace amounts 
in the nuclear membrane and some vesicles [87]. Adenylate kinase was found to co-purify and 
presumably interact with glycolytic enzymes and associate with myofibrils, cellular and mitochondrial 
membranes [21,26,33,51,73,74,78,113]. Adenylate kinase was also found to be engaged in intimate 
functional/structural interactions with the sarcolemmal KATP channel, a major metabolic sensor 
[33,46,47]. More recently, a phosphotransfer enzyme anchoring protein FHL2 was discovered in heart 
muscle [76]. This protein positions adenylate kinase and other phosphotransfer enzymes close to ATP 
utilization sites in myofibrils ensuring that both high-energy phosphate bonds of ATP are efficiently 
utilized. Mutation of the FHL2 protein is associated with cardiomyopathy [76]. Another adenylate 
kinase anchoring protein, Oda5p, anchors adenylate kinase in the proximity of the dynein arm ensuring 
that both high-energy phosphate bonds of ATP are efficiently utilized at the major site of power 
production of the microtubule motors involved in diverse cellular movements [57,70]. In epididymal 
spermatozoa adenylate kinase AK1 interacts with sperm associated protein P25b within cholesterol- 
and sphingolipid-enriched membrane domains [114]. Such association and localization is necessary for 
peri-membrane space ATP homeostasis and for sperm maturation and fertilization [114].  
A direct interaction between adenylate kinase and several enzymes of the dNTP synthase complex, 
as well as nucleoside diphosphate kinase was demonstrated using protein affinity chromatography and 
immunoprecipitation [115]. These results identified adenylate kinase as a specific component of the 
nuclear dNTP synthase complex, where it facilitates the survey of nucleotide ratios and the synthesis 
of nucleotides necessary for error-free DNA replication. Although topological positioning of specific 
proteins is crucial in energetics and signaling processes, the full interactome of adenylate kinase 
isoforms in cardiac muscle and other tissues is still unknown. In summary, molecular diversity and 
intracellular arrangement of adenylate kinase isoforms serve as a prototype of energetic and metabolic 
monitoring network where the localization of enzymes, their kinetic properties and the ability to 
communicate between different compartments play a critical role. 
3. Adenylate Kinase Catalyzed β-Phosphoryl Transfer and Energy Economy 
Adenylate kinase’s unique energetic function allows the utilization of the second high-energy bond 
of the β-phosphoryl in the ATP molecule, thereby doubling the energetic potential, a property not Int. J. Mol. Sci. 2009, 10                 
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shared by other phosphotransfer systems [1,5,12,20,26,29]. This catalytic function of adenylate kinase 
is particularly important in tissues with high and fluctuating energy demands, as well as those under 
metabolic stress [1,2,5]. It is also important for the intimate energy supply to specific cellular 
processes such as cell ciliary, flagella or cytoskeleton based motility [8,20,29-31]. A concerted action 
of both cytosolic and mitochondrial adenylate kinase isoforms is required to facilitate high-energy 
phosphoryl delivery to cellular ATPases and feedback signal communication to mitochondrial 
respiration within structurally organized enzymatic modules and networks (see Figure 1) [1,26,29,31]. 
In these networks, a series of rapidly equilibrating reactions catalyzed by adenylate kinase provide the 
driving force for high-energy phosphoryl flux [1,5,30]. In addition, adenylate kinase coupled with 
creatine kinase and glycolytic pathways communicate adenine nucleotide flux changes generated by 
cellular ATPases to metabolic sensors [5,29,33,37]. In such a way phosphotransfer reactions 
synchronize electrical and mechanical activities with energy supply processes, which is fundamental 
for optimal function of the heart [44,116]. Adenylate kinase is one of principle components in the 
generation of metabolic oscillations by sustaining dynamic fluctuations of adenine nucleotide ratios 
[5,29,117,118]. In this regard, the term of excitable “adenylate kinase medium” has been proposed 
[119] to emphasize the significance of this enzyme in conveying energetic and metabolic signals 
[5,33]. These functions render adenylate kinase essential to the integrated cellular phosphotransfer 
network sustaining an efficient and vibrant cell energetic economy. 
Further insights and key support for the current understanding of metabolic signaling networks in 
their full complexity have come with the development of new methodologies [1,4,15,31,44,60]. High-
energy phosphoryl fluxes through adenylate kinase, captured with 
18O-assisted 
31P-NMR, tightly 
correlated with the performance of the myocardium under various conditions of stress load [120]. This 
implicates that adenylate kinase along with other phosphotransfer reactions are indispensable routes 
that direct flow of high-energy phosphoryls between cellular ATPases and the ATP production 
machinery in mitochondria [44]. Labeling studies indicate that in intact tissues the highest adenylate 
kinase-catalyzed β-phosphoryl phosphotransfer flux is in the kidney, which approximates 98% of γ-
ATP turnover, followed by the liver (80%), the heart (15 – 22%) and contracting (10 – 17%) or resting 
(3 – 5%) skeletal muscles suggesting an important role of adenylate kinase in tissue energy 
homeostasis [5,30,41]. Specifically, the total adenylate kinase enzymatic capacity measured in vitro in 
murine heart is about 6 mM/s, while the phosphotransfer flux in vivo is between 0.2 -0.3 mM/s, it 
increases with functional load and can reach 1 mM/s in hypoxia and is expected to rise even more in 
ischemia [5]. For comparison, the range of phosphotransfer capacities of creatine kinase and glycolytic 
pathways are 6-10 mM/s and 2-3 mM/s, respectively [5]. In this regard, activities of adenylate kinase 
isoforms and intracellular free AMP levels tightly correlate with tissue respiration rates [16,121] and 
expression of adenylate kinase isoforms increases in response to muscle exercise, hypoxia, and 
metabolic stress [107,108]. Indeed, adenylate kinase remains active in its ATP regenerating and 
transferring role as long as ADP is available and the enzyme is not inhibited by a build-up of AMP 
[12,13]. Adenylate kinase phosphotransfer flux is markedly suppressed by high glucose in insulin 
secreting cells, reducing adenylate kinase-mediated AMP signaling to the K-ATP channel and AMPK, 
two key regulators of hormone secretion [45,122]. There is a reciprocal compensatory relationship 
between adenylate kinase and creatine kinase phosphotransfers to safeguard cellular energy economy: Int. J. Mol. Sci. 2009, 10                 
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reduction of creatine kinase activity promotes high-energy phosphoryl transfer through the adenylate 
kinase system in creatine kinase-knockout muscles or under hypoxic stress [1,15,28,36,60].  
The condensed mitochondrial structures and a very narrow intracristal space in the living cell poses 
diffusional limitations for nucleotide exchange [29]. Adenylate kinase (AK2) in the intermembrane 
space appears necessary to conduct the ADP stimulatory signal through the adenine nucleotide 
translocator to matrix ATP-synthases, as well as in exporting ATP produced by oxidative 
phosphorylation [2,21,29]. Disruption of the adenylate kinase gene impedes ATP export and 
mitochondria-cytosolic communication in yeast [101]. Muscles of AK1 knockout mice display lower 
energetic efficiency, slower relaxation kinetics and can not sustain low ADP levels under a functional 
load despite the presence of active creatine kinase, mitochondrial oxidative phosphorylation and 
glycolytic/glycogenolytic ATP-regenerating pathways, indicating disruption of the coherent energetic 
network with blunted response to metabolic signals [15,40-42]. Genetic disruption of both cytosolic 
M-CK- and AK1-catalysed phosphotransfer pathways compromises intracellular metabolic 
communication and energetic efficiency, reducing the cellular capability to maintain total ATP 
turnover under functional load [39]. These new methodologies and transgenic gene manipulations 
provide the opportunity to decipher regulatory mechanisms that underlie cardiac and skeletal muscle 
bioenergetic homeostasis. 
Taken together, studies of adenylate kinase gene-knockout models have opened new perspectives 
for the further understanding of how cellular energetic and metabolic signaling networks integrate with 
genetic, biosynthetic, membrane-electrical and receptor-mediated signal transduction events 
[2,5,32,33,35,39]. Gene-knockout studies also revealed a remarkable plasticity of the cellular 
phosphotransfer system, where deficiency in an individual enzyme is compensated through the 
remodeling of the whole energetic network at enzymatic, architectural and genomic levels 
[15,36,123,124]. Unexpectedly and contrary to common beliefs that adenylate kinase promotes 
nucleotide degradation, the AK1 deficient heart had less ability to maintain nucleotide pools under 
metabolic stress [32,35]. Also, in failing hearts adenylate kinase activity tightly correlates with higher 
cellular adenine nucleotide content [49,50], indicating a new function for adenylate kinase to safeguard 
the cellular nucleotide pool by rephosphorylating AMP back to ADP and ATP.  
Emphasizing the significance of intact energetic and metabolic signaling, AK1 deficiency is 
associated with a range of compensatory changes in glycolytic, glycogenolytic and mitochondrial 
metabolism and corresponding gene expression to support energy metabolism [4,15,32,35,39,123]. In 
this regard, one of the major finding resulting from adenylate kinase and creatine kinase knockout 
studies was the discovery that glycolytic/glycogenolytic enzymes have the ability to provide a network 
capacity for transferring and distributing high-energy phosphoryls [1,5,36]. The function of the adaptor 
protein DRAL/FHL-2, which anchors adenylate kinase, creatine kinase and glycolytic enzymes to sites 
of high energy consumption in myofibrils [76], further highlights the significance of the topological 
arrangement and integration of the intracellular phosphotransfer network in matching cellular   
energetic needs. 
In summary, adenylate kinase-facilitated high energy phosphoryl transfer and coordination between 
cellular sites of ATP consumption and ATP generation are essential for the safeguard of the cellular 
nucleotide pool and energy economy. Although significant progress has been made, there are still 
significant unanswered questions concerning adenylate kinase physiology, especially regarding the Int. J. Mol. Sci. 2009, 10                 
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energetic role of mitochondrial intermembrane AK2 and matrix AK3, nuclear AK6, ciliary AK7 and 
other tissue specific adenylate kinase isoforms. 
4. Adenylate Kinase and AMP Signaling: An Integrated Metabolic Monitoring and Signal 
Communication System 
Growing evidence indicates the significance of metabolic monitors which directly sense cellular 
energy state and respond to metabolic imbalances by generating and delivering signaling molecules to 
metabolic sensors and effectors to produce a regulatory response [1,2,5,52,62]. Central in metabolic 
monitoring is the enzyme adenylate kinase which constantly reads cellular adenine nucleotide balance, 
and, in case of disparity, generates AMP signals and facilitates their delivery to a number of AMP-
sensitive components, including those in the gycolytic and glycogenolytic pathways and to metabolic 
sensors and effectors such as K-ATP channels and AMPK, which adjust tissue energy and body 
hormonal state (Figure 3) [5,29,37,61]. Both K-ATP channels and AMPK can regulate cellular energy 
balance through managing Ca
2+ influx and by phosphorylating targeted proteins [5,44]. Due to a 
unique property of the adenylate kinase-catalyzed reaction, a small decrease in ATP levels results in a 
large increase in AMP, making the latter a sensitive indicator and therefore a suitable signaling 
molecule of cellular energetic status [1,5,62]. In recent years AMP signaling is emerging as one of the 
most versatile system in the regulation of diverse cellular processes [5,72]. Importantly, AMP signals 
must be integrated and tuned to an appropriate level, since low or excess AMP signaling, due to 
metabolic, hormonal state or metabolic sensors mutations, are associated with disease conditions 
[5,29,37,61,62,72,125]. As a result of adenylate kinase-mediated metabolic monitoring and AMP 
signaling (Figure 3), the activity of ATP generating pathways is increased while ATP-consumption  
is decreased.  
Figure 3. Adenylate kinase metabolic monitoring system. 
 
Adenylate kinase reads the cellular energy state, generates, tunes and communicates AMP signals 
to metabolic sensors. In such way adenylate kinase conveys information about the adenine 
nucleotide pool status and, thus, the overall energy balance. In response to AMP signals metabolic 
sensors reduce ATP-consuming and activate ATP-generating pathways to adjust energy 
metabolism, functional activity and increase fuel and oxygen supply. Int. J. Mol. Sci. 2009, 10                 
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In particular, adenylate kinase phosphotransfer directly couples with K-ATP channels, facilitating 
the translation of metabolic signals critical in adjusting cellular excitability-dependent functions in 
response to demand [1,33,37,46,47,61]. In the intracellular environment where diffusion is restricted, 
reactions tend to depend strongly on the local rather than global concentrations of metabolites [37]. In 
this way, adenylate kinase-catalyzed AMP signal generation and nucleotide exchange in the intimate 
“sensing zone” of metabolic sensors regulate the dynamics and frequency of ligand switching in order 
to facilitate decoding of cellular information [5,30,44]. Indeed, intracellular measurements using the 
18O-assisted 
31P NMR and mass spectrometric techniques indicate that adenylate kinase is uniquely 
situated to tune the magnitude of the AMP signal because its phosphotransfer displays only a fraction 
of total capacity, is compartmentalized and not universally at equilibrium, thus it can differentially 
promote both AMP signal generation and AMP rephosphorylation [1,4,28,31,36,38,45,60,120,126]. In 
this way, adenylate kinase through negative and positive feedback loops governs adenine nucleotide 
and glycolytic oscillations providing a dynamic component for facilitated intracellular energetic signal 
communication [5,29,117,119]. Moreover, through a series of spatially linked enzymatic reactions 
adenylate kinase facilitates propagation of nucleotide signals in the intracellular and extracellular 
space, thus coordinating the response of metabolic sensors and nucleotide/nucleoside receptor 
signaling [1,5,64,65]. Therefore adenylate kinase provides sustained communication between cytosolic 
and nuclear processes coordinating cell energetic and genomic events [30,34] and between 
myocardium and vasculature regulating coronary flow and oxygen delivery [4]. 
Adenylate kinase-induced increase in AMP promotes the generation of adenosine, a powerful 
metabolic signaling and cardioprotective agent [60,104]. AMP also triggers AMPK activation, an 
essential signaling module in cellular adaptation to stress [42,52,62,127]. In the heart, the significance 
of AMPK is suggested by the findings that AMPK activity is increased in ischemia and 
preconditioning, and that AMPK agonists protect myocardium against ischemic injury [127,128]. 
Hypoxia or metabolic stress increases adenylate kinase flux inducing AMP generation and downstream 
AMP/adenosine signaling events important in cardioprotection [1,59,63,104]. Adenylate kinase 
deficiency compromises metabolic signal reception by metabolic sensors, such as K-ATP channels and 
AMPK producing a stress vulnerable phenotype [33,42]. In this regard, new data suggests that 
hydrolysis of AMP by CD73 on graft-resident or circulating cells regulates endothelial barrier function 
and diminishes transendothelial leukocyte trafficking and mitigates inflammatory and immune 
response of cardiac transplantation via the A(2B) adenosine receptors [129]. Thus, adenylate kinase-
mediated AMP signaling through metabolic sensors and nucleoside receptors is an integral part of 
cellular stress response system. 
Adenylate kinase does not act alone in performing cellular metabolic monitoring. Recent evidence 
indicates that the interaction between adenylate kinase and creatine kinase phosphorelays determines 
metabolic signal communication to the K-ATP channel and mediates energetic remodeling in 
preconditioned and failing hearts [29,33,34,37,41,44,116]. Under normal conditions creatine kinase 
suppresses adenylate kinase phosphotransfer by scavenging cellular ADP [28] and thus maintaining 
the K-ATP channels in the closed state with low metabolic signaling through the AK → AMP → 
AMPK and AK → AMP → adenosine axis [33,52,61,105,116]. However, hypoxia or metabolic stress 
diminishes creatine kinase and increases adenylate kinase flux inducing AMP generation and 
downstream AMP/adenosine signaling events to adjust cellular energy balance [1,60,63,126]. Indeed, Int. J. Mol. Sci. 2009, 10                 
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deletion of the AK1 gene shifts this balance towards the creatine kinase system, compromising 
energetic signal communication [4,33,35,39]. Accordingly, AK1 deficiency blunts metabolic signal 
reception by metabolic sensors, such as K-ATP channels and AMPK, compromising their ability to 
withstand energetic stress [33,42]. Underscoring the significance of phosphotransfer redistribution in 
metabolic signaling is the observation that altered adenylate kinase and creatine kinase 
phosphotransfer enzyme activities are associated with hypertrophy, abnormal vascular tone and 
hypertension [105,130,131].  
The role of adenylate kinase in integrating signaling pathways is further indicated by the recent 
demonstration that AMP-stimulated AMPK regulates vascular response to hypoxia and nitric oxide-
dependent vasorelaxation as well as excitation of the oxygen-sensing carotid body which is critical for 
detection of O2 deficit in the bloodstream and adjustment of breathing pattern [132-134]. In addition, 
adenylate kinase appears to be the major phosphotransfer system in extraocular muscle, where, 
together with creatine kinase, it regulates precise eye movements [135]. A more recent study suggests 
that intracellular and extracellular adenylate kinase plays an important role in nucleotide energetic 
signaling regulating actin assembly-disassembly involved in cell movement and chemotaxis [136]. 
Thus, the balance between phosphotransfer systems and subsequent signaling events determine the 
outcome of metabolic regulation of muscle contractility, electrical activity and vascular tone. 
In recent years, adenylate kinase-mediated extracellular AMP and ADP signaling has gain an 
additional significance due to the involvement in high-density lipoprotein (HDL) endocytosis, in 
signaling through adenosine and AMP-specific receptors [137] and through AMP and other 
metabolite-sensing RNA riboswitches [138, 139], as well as in cell differentiation, tumor suppression 
and regulation of vascular tone [5,30,45,51,53,55,64,65,140,141]. In this regard, metabolic monitoring 
system in procaryotic cells utilizes RNA structures embedded at the 5' ends of mRNAs to sense 
particular metabolic cues and regulate the encoded genes [142]. By sensing the energy status of muscle 
cells and regulating gene expression, the adenylate kinase and downstream AMP signaling are critical 
regulators of mitochondrial biogenesis, through the AMPK-PGC-1  signaling cascade,  　 thereby 
increasing the energy transducing capacity of the cell [138,143]. Moreover, adenylate kinase through 
AMP signaling regulates glycolytic and glycogenolytic pathways conveying information regarding 
increased energy demand [5]. Regulation of glycogen metabolism is of primary importance in muscle 
energetics, including that of the heart [5,144]. Particularly, defective AMP and AMPK signaling is a 
primary cause of imbalance in glycogen metabolism and associated disease conditions [145]. 
Adenylate kinase metabolic monitoring plays a significant role in plant tissues [146]. Modulation of 
plastidial adenylate kinase activity and consequently AMP and adenine nucleotide levels significantly 
increases starch yield and amino acid biosynthesis [147,148], while overexpression of adenylate kinase 
in yeasts markedly increases ATP production [149]. Thus, adenylate kinase by providing ATP β-
phosphoryls for energetic needs and by regulating nucleotide ratios and AMP signaling adjusts the 
efficiency of energy metabolism, the capacity of ATP generating reactions and the activity of 
biosynthetic processes.  
Intracellular energetic and metabolic signal communication can employ several different 
mechanisms ranging from facilitated diffusion to ligand conduction, depending on cell type and 
specific compartment, structural organization and topological arrangement of enzymatic networks 
[29,30]. While spatial heterogeneity and directionality of the enzyme-catalyzed process is not Int. J. Mol. Sci. 2009, 10                 
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important in well mixed conditions in vitro, this becomes very important entity in highly organized 
living matter [150]. The cluster organization of enzymes and the high rate of unidirectional phosphoryl 
exchange in phosphotransfer systems would promote ligand conduction and signal communication at 
cellular distances [1,29,30]. Adenylate kinase facilitates mitochondria-nuclear energetic 
communication [34] and within the nucleus, embedded into organized enzymatic complexes of 
nucleotide-metabolizing and phosphotransfer enzymes, is involved in maintaining proper nuclear 
dNTP ratios and facilitates channeling of nucleotides into DNA replication machinery [115]. 
Imbalances in dNTP ratios affect the fidelity of DNA replication and repair leading to acquired 
mutations [30,115]. Thus, adenylate kinase surveys nucleotide ratios necessary for error-free DNA 
replication, while another nuclear protein Rad50, harboring adenylate kinase activity, participates in 
DNA double-strand break repair [93].  
Despite recent advances in the metabolic signaling field, more studies are necessary to elucidate 
mechanisms which link adenylate kinase phosphotransfer flux, AMP signal dynamics and the response 
of metabolic sensors (AMPK, K-ATP), as well as the significance of AK → AMP → AMP-sensors 
signaling system in heart physiology, such as in shaping heart force-frequency relationship and Frank-
Starling response, and cardioprotection [5,44]. At the molecular level, studies of multienzyme 
complexes including adenylate kinase would shed light on intimate mechanisms of metabolic sensing. 
Co-localization of components in signal transduction cascades is critical for the directionality and 
specificity of the signaling response. The presence of adenylate kinase in close proximity of AMPK 
would facilitate metabolic signal transduction and create a favorable energetic environment for the 
phosphorylation of targeted proteins. The significance and downstream mechanisms by which   
AK → AMP → AMPK signaling axis regulate cell cycle, developmental potential, and timing of 
differentiation are just starting to be elucidated. Thus, although more studies are needed, adenylate 
kinase-mediated metabolic monitoring and downstream AMP signaling is increasingly recognized 
among major homeostatic mechanisms in a number of cells, critical in the regulation of diverse cellular 
processes and stress-response. 
 
5. AMP as Universal Fuel Consumption and Low Energy Signal, Mediator of Drug Action and 
Therapeutic Agent 
 
Metabolic signals regulate and integrate many vital functions throughout the human body, including 
energy homeostasis, blood pressure, heart performance, food intake, hormonal status and brain 
performance [30,71]. Recent evidence suggests the general importance of adenylate kinase-mediated 
AMP signaling in appetite, wakefulness and sleep control and in hormonal, food and antidiabetic drug 
actions which are coupled to alterations of cellular AMP levels and associated signaling 
[4,5,46,47,55,62-70,86,138,151]. AMP signaling also plays an important role in hypoxic response, 
immune function and taste reception [60,85,129,137,139]. Adenylate kinase integrates and tunes AMP 
signals coming from different sources and delivers them to metabolic sensors to elicit a regulatory 
response (Figure 4). Reduced or increased adenylate kinase activity would distort integration of AMP 
signals and, depending on tissue metabolic phenotype and intensity of AMP-generating reactions, 
could produce both positive and negative impact on the activity of metabolic sensors [42,152]. 
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Figure 4. AMPing up and down ― integration cellular AMP signals by adenylate kinase. 
 
 
Adenylate kinase integrates AMP metabolic signals produced or downregulated during exercise, 
stress response, food consumption and during changes in hormonal balance or mitochondrial 
coupling state. Adenylate kinase relays deliver AMP signals to metabolic sensors and by catalyzing 
nucleotide exchange in the intimate “sensing zone” of metabolic sensors facilitate decoding of 
cellular information. 
 
Recent evidence suggests that ingestion of fructose, a major constituent of sugar and high-fructose 
corn syrup, causes increase in cellular AMP and AMP/ATP ratio leading to activation of AMPK [68, 
153]. Contrary to glucose, which usually lowers cellular AMP levels and inhibits AMPK, fructose 
activates hypothalamic AMPK and increases food consumption (Figure 4) [68]. Compared with 
glucose-sweetened beverages, consumption of fructose-sweetened beverages with meals elevates 
postprandial plasma triglycerides and lowers 24-h insulin and leptin profiles in normal weight women 
[154]. Fructose metabolism bypasses the rate-limiting step of the glucose pathway, and is metabolized 
much more quickly than glucose. Excessive fructose intake depletes cellular ATP by trapping 
inorganic phosphate required for ATP resynthesis, consequently inducing nucleotide degradation and 
increasing plasma uric acid and allantoin levels [155]. These metabolic alterations induced by fructose 
may play an important role in the epidemic of metabolic syndrome and may contribute the 
development of diabetes and cardiovascular disease [156]. A diet high in fructose can give rise to 
hyperlipidemia, insulin resistance and hypertension [157]. Similarly, ethanol consumption and 
subsequent acetate metabolism causes AMP accumulation in liver and other tissues resulting in 
increased AMP and adenosine signaling and blood flow [158,159]. Excess ethanol consumption can 
also cause nucleotide degradation and depletion of cellular adenine nucleotide pool [160]. However, 
short term and limited exposure to fructose and ethanol could be beneficial in stimulating energy 
metabolism and metabolic signaling, thus “AMPing” your body [153,161]. In this regard, 
cardioprotection induced by both fructose and ethanol preconditioning stimuli could be related to 
augmented AMP signaling [162,163]. Int. J. Mol. Sci. 2009, 10                 
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Figure 5. Regulation of intracellular AMP levels. 
 
Cytosolic adenylate kinase (AK1) is the major AMP generator while mitochondrial AK2 isoform, 
due to low Km(AMP), is the major AMP sequestration and tune-up mechanism. AMP is also 
generated during free fatty and amino acid activation, during adenosine rephosphorylation by 
adenosine kinase (ADK), during IMP reamination and by cyclic nucleotide phosphodiseterase 
(PDE). Oxygen deprivation and intense muscle contraction increase AMP removal through 
adenosine and IMP pathways catalyzed by 5’-nucleotidase (5’-NT) and AMP-deaminase (AMPD). 
Defects in mitochondria metabolism would reduce AMP tuning capacity of AK2 and, in fact, can 
reverse reaction towards AMP generation. The metabolically active AMP pool, estimated about 10-
20%, is in dynamic equilibrium with bound and/or compartmentalized AMP [1,5].  
 
Normal human blood AMP levels are in the 10-20 µM range of which only a fraction is free due to 
binding to serum proteins [164]. Intracellular and blood AMP levels are increased during physical 
activity and are sensitive indicators of myocardial ischemia rising within minutes after insult 
[165,166]. Adenylate kinase isoforms provide fine tuning of intracellular, interstitial and circulating 
AMP levels due to different kinetic properties and localization (Figure 5). Deficiency of AK1 isoform 
reduces the AMP signal stress response [4,32,33,35,42], however at the basal level it could result in 
higher AMP signaling due to compromised tune-up mechanisms [152]. Circulating AMP is emerging 
as a molecular mediator of hibernation and constant darkness effect, switching mice from a glucose-
burning, fat-storing state to a fat-burning, glucose-conserving lethargy [66]. In hibernating mammals 
AMP originating, at least partly, from the brown fat also down-regulates the seasonally-dependent 
proliferation of the thymus [167]. In addition, overworked brains release adenosine, usually originating 
from AMP, to slow cell activity and trigger sleep [168,169]. These data strongly support the notion 
that AMP and adenosine play a key role as endogenous modulators of wakefulness and sleep which 
fits with our proposed role of phosphotransfer reactions in regulating brain activity and information 
processing [30]. 
Available evidence suggests that growth factors, which alter cellular energy metabolism, and 
hormones, such as adipocyte-derived leptin and adiponectin, activate AMPK through local or temporal 
regulation of AMP levels [170-172]. Leptin alters muscle adenine nucleotide homeostasis (decreases 
ATP) and increases AMP dynamics (inferred from elevated AMP and IMP levels) followed by Int. J. Mol. Sci. 2009, 10                 
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activation of AMPK [173-175]. This could be also due to increased expression of uncoupling proteins 
(UCP) - mitochondrial carriers that dissipate the electrochemical gradient across the mitochondrial 
inner membrane [176,177]. Mild uncoupling of mitochondria shift cellular nucleotide balance and, due 
to the monitoring function of adenylate kinase, AMP levels would go up triggering metabolic signaling 
cascades [176,177]. Interestingly, AMP by itself through interaction with ANT can produce 
uncoupling that could facilitate respiration and reduce ROS production [178], which could be 
beneficial during ischemia reperfusion.  
AMP signaling plays a significant role in cellular senescence. It’s been shown by proteome analysis 
that AK1 protein is markedly increased in senescent skeletal muscle fibers [179] and that lifespan of 
worms can be extended by the addition of copies of the AMPK gene and by chronic activation of 
AMPK as is seen on calorie-restricted diets [180]. Indeed, AMP/ATP ratios are several folds higher in 
senescent fibroblasts compared with young fibroblasts and this is accompanied by a marked elevation 
in AMPK activity [181,182]. This could be viewed as a compensatory measure to cope with declining 
capacity of energy metabolism during aging. AMP and AMPK signaling is critical in cell 
differentiation, maintaining cell polarity and completing normal cell division as well as in induction of 
meiotic maturation in mammalian oocytes [183-185]. AMP directly or through AMPK plays a 
physiological role in modulating activity of cystic fibrosis transmembrane conductance regulator 
(CFTR) in polarized epithelia cells [186,187]. CFTP nucleotide binding folds possess an intrinsic 
adenylate kinase activity which could facilitate metabolic signal reception [61,188]. Thus, AMP 
signaling plays a critical role in altered hormonal and energetic states including cell differentiation, 
maintenance of polarity and senescence.  
AMP is important mediator of insulin and metabolic protein kinase Akt signaling. It has been 
proposed that protein kinase Akt mediates inhibitory effects of insulin on AMPK [189]. Since Akt 
does not directly phosphorylate AMPK, changes in Akt activity induced by insulin can regulate 
AMPK through changes in cellular AMP/ATP ratio. Indeed, it was demonstrated that Akt activation 
reduces cellular AMP/ATP ratio causing decline in AMPK activity [190]. Insulin and Akt-mediated 
inhibition of AMPK can be overcome by metformin, which is known to act on site I of mitochondrial 
respiratory chain causing increase in AMP levels [189,191]. In this regard, free fatty acids, which 
activation generates AMP, prevents AMPK inhibition by insulin [192]. Thus, insulin-Akt signaling 
axis can expand the range of metabolic effects through tuning up AMP signals and the activity   
of AMPK. 
Most importantly, recent studies indicate that pharmacological actions of popular antidiabetic drugs 
metformin and thiazolidinediones and cholesterol lowering statins are related to their ability to alter 
cellular AMP levels and consequently AMPK activity [151,193-195]. Time course studies revealed 
that troglitazone-induced increases in phosphorylated forms of AMPK and ACC are paralleled by an 
increase in the AMP-to-ATP ratio [193]. A similar increase in AMP is seen following incubation of 
cells with rosiglitazone [196]. Moreover, livers of rats treated with resveratrol, a constituent of red 
grapes and red wine, show a strong tendency for AMPK activation, as well as increase 
phosphorylation of two downstream indicators of its activity [197]. Besides inhibiting HMG-CoA 
reductase, statins preserve CD39/ATPDase activity in thrombin-treated endothelial cells [198]. 
Preservation of adenine nucleotide metabolism may directly contribute to the observed anti-thrombotic 
and anti-inflammatory actions of statins. In this regard, metformin, a biguanidine compound from Int. J. Mol. Sci. 2009, 10                 
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French lilac and more recently extracts from bitter melon, a traditional Chinese medicine, activate 
AMPK and exerts its glucose lowering effect through mild interference with the efficiency of energy 
metabolism resulting in changes in intracellular nucleotide dynamics and AMP levels [151,194,199]. 
Through activating AMP signaling metformin also improves cardiac function after ischemia in rats 
[200, 201]. Interestingly that metformin increases glucose utilization and lactate production in cells 
with a dominant-negative mutant form of AMPK (DN-AMPK) [202], suggesting existence of AMPK-
independent pathways of metabolic signaling including direct effects of AMP on other metabolic 
sensors and enzymes of energetic pathways. 
Recent interest in clinical use of adenosine as “adenosine flush” and in reperfusion therapy is also 
associated with AMP signaling, activation of AMPK and replenishment of cellular ATP levels [203-
205]. Adenosine, besides signaling through adenosine receptors, can be taken up by cells and 
phosphorylated to AMP initiating metabolic signaling cascades [104,206]. Subsequent conversion of 
AMP to ADP and ATP by reactions involving adenylate kinase and ATP synthesis in mitochondrial 
oxidative phosphorylation and glycolysis would replenish cellular ATP and total adenine nucleotide 
pool which is diminished during ischemic insult [104,206]. Thus, adenosine and AMP have pleiotropic 
metabolic signaling and energetic effects which could be further explored in reperfusion therapy. 
Last but not least, AMP through interaction with taste receptors has the bitterness-suppressing 
quality that allows taste buds to interpret food as seeming “sweeter” [207]. This makes lower-calorie 
food products more palatable. Recently AMP has been approved by the FDA as a 'Bitter Blocker' 
additive to foodstuffs (Linguagen Corp.). AMP is found in a wide range of natural foods — including 
breast milk. Calcium compounds in breast milk are usually bitter and thus breast milk may be natural 
system using bitter-blockers. AMP also inhibits behavioral and electrophysiological responses of mice 
to bitter tastants [207]. A number of AMP containing medications are used for nutritional 
supplementation and for treating dietary shortage or imbalance and disease conditions [208]. 
Nucleotides such as AMP affect a number of immune functions, including the reversal of malnutrition 
and starvation-induced immunosuppression due to adenine nucleotide shortage, the enhancement of T-
cell maturation and function and natural killer cell activity [208]. However AMP by itself has 
immunosuppressive properties. In fact, mosquito and fly saliva contains AMP and adenosine as 
vasodilatative agents which also have immunosuppressant activity facilitating pathogen or parasite 
transmission [209]. To this end, secreted and cell associated adenylate kinase has been identified as a 
virulence factor in a number of pathogens affecting nucleotide signaling and host immune defense 
[210]. Due to immunomodulatory function, a promising therapeutic potential for the AMP analog 
AICAR/(ZMP) exist in the treatment of multiple sclerosis and other Th1 cell-mediated inflammatory 
diseases such as psoriasis and arthritis [211]. Thus, AMP is emerging as pivotal metabolic signal 
conveying information about food consumption, hormonal and energy metabolism status, a regulator 
of brain activity associated with wakefulness and appetite control as well as a mediator of drug action 
and therapeutic agent. 
6. Adenylate Kinase and AMP Signaling Networks in Body Energy Sensing 
Sensing body energy level and corresponding mental and physical strength is important for humans 
and animals and this property had key survival and evolutionary advantages [5,30,72,212-216]. Here Int. J. Mol. Sci. 2009, 10                 
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we further advance the hypothesis that body energy sensing is mediated in part by adenylate kinase, 
which conveys information about the adenine nucleotide pool status and, thus the overall energy 
balance [5,30]. The general concept has been proposed previously by H. Teagtmeyer [217] that 
systemic metabolic communication and energy transfer arises from the interaction of a series of moiety 
conserved cycles operating through tissues and circulation.  
 
Figure 6. Myocardial-vascular metabolic signaling as a paradigm of global energy sensing. 
 
Metabolic signal transduction cascades initiated by phosphotransfer redistribution between 
adenylate kinase (AK) and creatine kinase (CK) govern AMP/adenosine (Ado) cycle and the 
response of metabolic sensors (ATP-sensitive potassium channel, K-ATP and AMP-activated 
protein kinase, AMPK). Hypoxia or metabolic stress diminishes CK and increases AK flux 
inducing AMP generation and subsequent AMP/adenosine signaling events. Adenosine/AMP 
signals delivered to vascular tissue through intercellular and paracellular pathways induce signaling 
through A(2A) adenosine receptors, AMPK and K-ATP channels. AMPK activates eNOS inducing 
NO/cGMP signaling and could regulate K-ATP channels. Collectively, A(2A)AR, AMPK, eNOS 
and K-ATP signaling converge on contractile protein, Ca
2+ and membrane potential regulation, 
critical determinants of vascular tone. Dipyridamole, an adenosine uptake inhibitor, disrupts Ado-
AMP cycle and tuning of adenosine signals, thus potentiating vascular response. Modified from [4] 
with permission.  
 
Phosphotransfer reactions have emerged as principle signal generators and coupling relays between 
cellular metabolism and metabolic sensors [5,29,30,44,218]. In particular, adenylate kinase as 
generator and modulator of metabolic signals is a critical player integrating complex AMPK and K-
ATP channel signaling cascades in regulation of hormone secretion, blood flow, stress response, 
muscle and brain functional activity [1,4,5,30,33,34,37,47]. A case in point is myocardial-vascular 
metabolic signal communication governed by phosphotransfer redistribution, metabolic cycles and 
relays culminating in a metabolic sensor and functional response (Figure 6) [4]. As brain function 
specifically depends on glucose metabolism, new spatial and network representation of glycolytic Int. J. Mol. Sci. 2009, 10                 
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pathway [5] allow for new perspectives and understanding of energetic signal communication and 
glucose sensing in neurons [30,212].  
Body energy sensing depends on information relayed and distributed to a central network of 
metabolic sensing neurons through hard-wired neural connections and by metabolic and hormonal 
signals from the periphery coming through the blood and interstitial fluids [212,214]. The brain has a 
specialized set of neurons that integrate many of these signals and produce regulatory response. These, 
first described as “glucose sensing” neurons, are really broad-range cellular metabolic sensors that 
have transporters, metabolite-sensing kinases, ion channels, and receptors that allow them to sense and 
interpret signals coming from the periphery [214].  
Metabolic sensing neurons are integrated into a network that links them to afferent and efferent 
pathways involved in the control of energy homeostasis [212]. Recent studies indicate that beside 
satiety hormonal signals, such as leptin and insulin, a myriad of metabolic inputs are generated and 
sensed by the brain including glucose, fructose, fatty acids and their metabolites, amino acids, Krebs 
cycle intermediates and nucleotides through specialized receptors and signaling cascades [212-216]. In 
many cases, reception or metabolism of these signals by sensing neurons results in altered intracellular 
ATP/AMP ratio and behavior of metabolic sensors such as AMPK, K-ATP channels and other 
regulators of firing activity [33,72,213,219,220]. This integrated information is then used not only to 
guide choices the animal makes about the amount of fuels to take in from the environment but also 
how stored fuels should be distributed and metabolized by various peripheral tissues. Molecular 
defects or a raise in threshold for sensing catabolic signals from the periphery by specialized metabolic 
sensing neurons is one of the causes of obesity [212-214].  
Metabolism sensing neurons are regulated by glucose through mechanisms requiring either the K-
ATP channel or the Na
+/glucose cotransporter SGLT3, which is a glucose-sensing rather than glucose-
transporting molecule [212-216]. In glucose-excited neurons, the decrease in ATP and ATP-to-ADP 
ratio leads to activation of K-ATP channels and plasma membrane hyperpolarization, and thus 
reduction in neuronal firing activity. In glucose-inhibited neurons, the reduced ATP-to-ADP ratio 
induces closure of chloride channels and/or reduction in the activity of the Na-K pump, depolarization 
of the plasma membrane, activation of voltage-sensitive Ca
2+ channels, and synaptic neurotransmitter 
secretion. Changes in energy expenditure are achieved by regulating hormonal status, sympathetically 
mediated thermogenesis and cellular energy sensors such as AMPK, which switch off ATP-consuming 
and activate ATP-regenerating pathways in response to cellular fuel shortage [212-214]. Recent 
studies show that activity of AMPK is increased in the brain in response to low levels of cellular fuels 
and negative energy balance and, contrary to peripheral tissues, decreased by leptin [72,213,219]. 
Furthermore, reduced activity of AMPK in the hypothalamus reduces food intake and body weight 
[213,219]. Circulating leptin levels give the brain input regarding energy storage so it can regulate 
appetite and metabolism. Although leptin is a circulating signal that reduces appetite, in general, obese 
people have an unusually high circulating concentration of leptin and develop leptin resistance   
[212-214]. Among other factors, consumption of high amounts of fructose causes leptin resistance 
[221]. This could be due to excess of AMP signaling in the periphery induced by both leptin and 
fructose which is conveyed to the brain as false “low energy” signal forcing it to increase food 
consumption. AMP and other peripheral metabolic signals apparently can overcome inhibitory leptin 
signaling circuits in the hypothalamus [68,153,175]. In this regard, a significant increase in adenylate Int. J. Mol. Sci. 2009, 10                 
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kinase isoform AK1 and other phosphotransfer enzymes in obese/overweight and morbidly obese 
women further indicate an imbalance in metabolic signaling in this metabolic syndrome [116]. 
Labeling studies of adenine nucleotide -phosphoryls indicate that adenylate kinase is active in the 
brain and that its phosphotransfer rate is increased by drugs improving cerebral circulation and 
memory dysfunction [222]. Similarly, photic stimulation increases adenylate kinase-mediated ATP β-
phosphoryl turnover in photoreceptors suggesting a role in energetics of these specialized cells [223]. 
Other studies indicate that adenylate kinase isoforms in the brain may contribute to neuronal 
maturation and regeneration [23,224]. Activation of melanocortin system, which is involved in 
regulation of appetite, metabolism and body weight, increases expression of adenylate kinase AK1 in 
the hypothalamus [225]. AMPK, a master metabolic sensor present in hypothalamus, responds to 
adenylate kinase integrated AMP levels, and plays a critical role in hormonal and nutrient-derived 
anorexigenic and orexigenic signaling [62,72,226]. Adenylate kinase AK2 is among 14 genes mapped 
in quantitative trait loci for body weight and abdominal fat weight [227]. Recent proteome studies 
revealed that adenylate kinase AK2 may be an important regulator involved in the anti-lipid and 
antioxidant effects of tomato paste [228]. The down-regulation of AK1 expression by hyperglycemia 
in pancreas may contribute to the defective coupling of glucose metabolism to K-ATP channel activity 
in type 2 diabetes [48].  
Information processing in the brain and energy sensing takes place not only intracellularly but also 
on extracellular surfaces and between different type of cells through intercellular connections 
[30,229,230]. In fact, brain ecto-adenylate kinase is an integral part of synaptosomal ATP-
metabolizing enzyme cascades regulating ATP, AMP and adenosine signaling [231]. Similarly, 
adenylate kinase by regulating nucleotide exchange and signaling at peripheral nerve endings can 
convey information regarding the energy state of particular tissues, thus contributing to body energy 
sensing. In other cell types ecto-adenylate kinase provides a mechanism for propagation of nucleotide 
based signals along the cellular surface, thus coordinating multiple receptor-mediated signaling events 
[64,65]. Extracellular AMP induces bronchoconstriction in suspected asthmatic patients and is used in 
disease diagnostics as a bronchial provocation test [232]. Both ATP and adenosine signaling which 
could be modulated by adenylate kinase are critical in synaptic transmission and for normal brain 
function [233]. Thus, the systemic adenylate kinase → AMP → AMPK signaling network represents a 
new modality in body energy balance. 
In different tissues, adenylate kinase activity depends on the nutritional and hormonal state 
[234,235]. Adenylate kinase phosphotransfer flux is markedly suppressed by high glucose in insulin 
secreting cells, reducing adenylate kinase-mediated AMP signaling to the K-ATP channel and AMPK, 
two regulators of hormone secretion [45,122]. In humans, deficiency of the AK1 isoform is associated 
with mental retardation, psychomotor impairment and congenital anemia [236]. In this regard, a strong 
correlation has been observed between fasting and higher expression of the adenylate kinase AK3 
isoform, UCP3 and increased activity of AMPK and fatty acid oxidation [237], suggesting an 
interrelated signaling cascade. Although the significance of energetic and metabolic signaling is 
growing, little is known regarding the regulation of adenylate kinase phosphotransfer under different 
metabolic, hormonal and functional states, and how such regulation affects the ability of the cell to 
generate and respond to energetic stress-related signals.  Int. J. Mol. Sci. 2009, 10                 
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A new emerging modality in extracellular and intracellular nucleotide signaling and information 
processing is the cAMP → AMP → adenosine/AMPK pathway sequentially connecting cAMP- and 
AMP-response elements [238]. In this pathway, cAMP signaling is followed by conversion of cAMP 
by phosphodiesterases to AMP that activates the AMP-signaling cascade [183]. The role of adenylate 
kinase in this system is envisioned to propagate AMP metabolic signals along the membrane surface or 
within the cytosolic space and nuclear compartment where AMPK resides [1,5,65,239]. Cosequently, 
production of adenosine from AMP by 5’-nucleotidase could stimulate adenosinergic signaling 
pathways [240]. Thus, this kind of integration of cyclic nucleotide →  nucleotide  → nucleoside 
signaling provides means of coordinating diverse signaling events and facilitating information transfer 
from one subsystem to another. 
Understanding principles governing integration and synchronization of metabolic sensors with 
cellular metabolism is important for regulation of cellular energetic and ionic homeostasis as well as 
hormonal balance and food intake [37,61,241-243]. Growing evidence and increasing number of 
discovered metabolic signaling cascades indicate that these systems are essential in vital cellular 
processes integrating gene expression, metabolism and response to stress, moreover their defects are 
associated with diseases under a wide umbrella of “metabolic syndrome” [33,62,243,244]. In this 
regard, recent studies indicate that metabolites linked to glucose such as succinate and alpha-
ketoglutarate can signal through specific G-protein-coupled receptors which are also present in 
neurons [245,246]. Glucose usually decreases adenylate kinase phosphotransfer flux and intracellular 
AMP levels and consequently adenosine signaling, but it can increase Krebs cycle substrate levels 
through anaplerosis [1,246]. Succinate and alpha-ketoglutarate also have signaling function in cell 
nucleus regulating DNA methylation, which has been implicated in obesity [247]. Taken together, 
emerging data indicate that coupling of “energetic” phosphotransfer enzymes with phosphoryl-
transfering protein kinase cascades and metabolite sensitive ion channels, transporters and receptors, 
comprise a unified intracellular and transcellular energetic and metabolic signal transduction matrix 
capable of processing, integrating and delivering cellular information regarding energy state (see 
Figure 6). Within this network, adenylate kinase and AMP signaling throughout the intracellular 
compartments, extracellular space and body fluids comprise a major metabolic monitoring and body 
energy sensing node, capable of transducing and distributing signals to metabolic sensors to adjust 
energy metabolism, fuel selection, food intake and functional response. 
7. Adenylate Kinase Never Rests: From Altered Energetic Signaling to Immunodeficiency, Cell 
Motility Defects, Reticular Dysgenesis and Sensorineural Deafness 
A thoughtful notion that “adenylate kinase never rests” was expressed by P.B. Detwiler more than a 
decade ago when commenting on the paper entitled “Adenine nucleoside diphosphates block 
adaptation of mechano-electrical transduction in hair cells” [248]. In this paper P.G. Gillespie and A.J. 
Hudspeth demonstrated that mechano-electrical signal transduction and adaptation by hair cells 
depends on adenine nucleotides and adenylate kinase reaction [248]. Indeed, the past decade further 
revealed that the dynamic behavior of the adenylate kinase reaction governs many intracellular and 
extracellular nucleotide signaling processes and that adenylate kinase mutations cause severe human 
disease phenotypes [1,2,8-11,22,30,102]. Int. J. Mol. Sci. 2009, 10                 
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Adenylate kinase in conjunction with other phosphotransfer rections is involved in metabolic 
signaling to membrane ion channels regulating cell ionic balance and electrical activity, and in energy 
supply to distant ATPases powering spermatozoa and other cell motility related processes 
[20,29,31,33,44,47]. The large molecular weight isoform AK7 is unusual in the adenylate kinase 
family; it contains a Dpy-30 motif involved in protein dimerization and is associated with cell motility 
and other processes [2,5,96]. Mutations in the evolutionarily conserved Ak7 gene results in animals 
presenting with pathological signs characteristic of primary ciliary dyskinesia (PCD), including 
ultrastructural ciliary defects and decreased ciliary beat frequency in respiratory epithelium [7]. Ak7 
appears to be a marker for cilia with (9 + 2) microtubular organization critical in motility, 
morphogenesis, cell division and immune response [7,97]. In humans PCD is a genetically and 
phenotypically heterogeneous disorder, characterized by progressive development of bronchiectasis, 
inflammation, and features characteristic of chronic obstructive pulmonary disease [7]. Thus, these 
results suggest that mutations of the human Ak7 gene may underlie a subset of genetically 
uncharacterized PCD cases. 
 More recently, the elegant work from B. Wieringa’s laboratory examining the adenylate kinase 
spatial positioning within a cell by utilizing different artificial location tags, demonstrate that 
cytoskeleton-based cell motility can be modulated by spatial repositioning of adenylate kinase 
enzymatic activity to provide local ATP supply and ADP scavenging capacity [8]. These results are 
corroborated by the use of another heterodimer-inducing approach for transient translocation of AK1 
to the specific cellular sites under conditions of constant global AK1 activity in the cell [8]. Thus, 
adenylate kinase functions as a coupling factor between local ATP supply and regulation of 
actomyosin and other molecular motor behavior, which is central to cell shape changes and cell 
motility. Similarly, creatine kinase–mediated ATP supply fuels actin-based events in phagocytosis and 
is required for thrombin receptor signaling to the cytoskeleton [249,250]. In this regard, the dynamics 
of actin and myosin in brain presynaptic and postsynaptic regions play a critical role in brain activity 
and memory formation, and consume the major fraction of the total energy in neurons [251,252]. It 
remains to be determined whether adenylate kinase provides energy support for motor proteins 
involved in neuronal trafficking and memory consolidation. Interestingly in humans, genetic adenylate 
kinase deficiency or losses of adenylate kinase from the brain after surgery are associated with 
compromise intellectual function [253,254]. 
Conversion of mechanical stimuli to electrical signals in stereocilia of inner ear hair cells is 
associated with Ca
2+ dynamics and movement of myosin motors, similar to many mechanoelectrical 
and ciliary motility systems [7,248]. The energy supply and nucleotide-based signaling coordinating 
behavior of such systems is provided by phosphotransfer enzymes including adenylate kinase 
[1,8,29,30]. It was demonstrated that the creatine kinase circuit is essential for high-sensitivity hearing 
as demonstrated by hearing loss in creatine kinase knockout mice [255]. Recently biallelic mutations 
in mitochondrial adenylate kinase AK2 gene have been identified in individuals affected with reticular 
dysgenesis [9]. Human reticular dysgenesis is the most severe form of inborn severe combined 
immunodeficiencies (SCID) associated with sensorineural deafness. This disease is characterized by 
the absence of granulocytes and almost complete deficiency of lymphocytes in peripheral blood. 
Mutations in AK2 gene result in absent or strong decrease in AK2 protein expression [9]. Restoration 
of AK2 expression in the bone marrow cells of individuals with reticular dysgenesis overcomes Int. J. Mol. Sci. 2009, 10                 
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neutrophil differentiation arrest, underlining its specific requirement in the development of a restricted 
set of hematopoietic lineages. Moreover, AK2 is specifically expressed in the stria vascularis region of 
the inner ear, which may provide an explanation of the sensorineural deafness in these individuals [9]. 
Interestingly, immunohistochemistry indicate that AK2 is present within the lumen of the stria 
vascularis capillaries suggesting that it could be functioning as an ecto-enzyme, however more detailed 
studies at the cellular level are required and different AK2 and other AK isoform antibodies should be 
tested. Since almost all cells contain mitochondria and intermembrane AK2, the negative result of 
intracellular AK2 immunohistochemistry could be related to inaccessibility of intermembrane proteins 
to antibodies.  
It is known that ecto-adenylate kinase plays an important role in extracellular nucleotide signaling; 
however it is unusual to detect a mitochondrial isoform outside the cell [64,65]. An intriguing 
possibility exist that beside nucleotide signaling, mucosa embedded AK2 has specific mechano-
metabolic signal transduction functions and behavior similar to that described in smart hydrogels 
containing adenylate kinase [256]. A recent proteome study indicates adenylate kinase is present in the 
extracellular mucus [257]. However, whether the adenylate kinase system due to mutation of AK2 is 
altered in primary mechanoelectrical signal transducing hair cells which have abundant mitochondria 
should be determined. Our data indicate that both AK1 and AK2 associate with mitotic spindle, which 
have microtubular organization (9 + 2) similar to cilia, apparently to power cell division cycle and 
chromosome disjunction. Previous studies have shown that disruption of analogous adenylate kinase 
Aky2 gene in yeast coding mitochondrial intermembrane and partially cytosolic AKY2 protein halts 
ATP export from mitochondria [99]. Thus, AK2 isoform, usually confined within mitochondrial 
intermembrane space, may have important extramitochondrial functions.  
That the gene encoding the mitochondrial energy metabolism related enzyme adenylate kinase 2 
(AK2) is mutated in individuals with reticular dysgenesis is supported by simultaneously published 
independent evidence [10]. Knockdown of zebrafish ak2 gene leads to aberrant leukocyte 
development, stressing the evolutionarily conserved role of AK2 in leukocyte differentiation [10]. 
Mononuclear cells obtained from bone marrow of healthy donors lacked AK1, whereas AK2 was 
readily detectable. These results indicate that leukocytes may be susceptible to defects caused by the 
lack of AK2, as they do not express AK1 in sufficient amounts to compensate for AK2 functional 
deficits. Previous studies have linked AK1 mutations to severe nonspherocytic hemolytic anemia and 
associated with mental retardation and psychomotor impairment [3,236]. In this regard, the deficiency 
of another metabolic enzyme adenosine deaminase (ADA) accounts for approximately 17% of all 
SCIDs and 50% of all autosomal recessive SCIDs [258]. The metabolic basis of this 
immunodeficiency is likely related to accumulation of the ADA substrates adenosine and 2'-
deoxyadenosine that kill T and B cells through mechanisms involving accumulation of dATP and 
induction of apoptosis [258]. Whether nucleotide metabolism is altered in AK2 mutant cells remains to 
be determined. Taken together, these observations suggest that reticular dysgenesis is the first example 
of a human immunodeficiency syndrome that is causally linked to the defective phosphotransfer 
enzyme involved in nucleotide signaling and mitochondrial energy metabolism. 
In this regard, absence or reduction of AK2 protein would interfere with mitochondrial 
bioenergetics and mitochondria-nucleus energetic signal communication that could compromise 
implementation of leukocyte developmental program [9,30,34]. Evolvement of mitochondrial network Int. J. Mol. Sci. 2009, 10                 
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and establishment of metabolic circuits are part of developmental programming and execution of cell 
differentiation sequences [259,260]. A recent study indicates that energy demand signaling gradients 
arising in the cell would allow propagation of information on local energy consumption over distances, 
through nucleotide-based signaling conveying positional information to mitochondria [261]. In such 
way, responding to energy demand gradients, mitochondria can pattern the cytoplasm over length 
scales that are suited to provide an energy supply continuum and convey morphogenetic information in 
large cells and tissues [259,261]. Thus, AK2 deficiency can disrupt the flow of developmental 
information governing cell differentiation.  
Adenylate kinase supports energetics and motility of flagella containing parasites and secreted 
adenylate kinase is a major virulence factor in a number of pathogenic bacteria [5,20,56,57,210]. 
Recently, a novel myristoylated AK2 isoform has been discovered in P. falciparum causing severe 
tropical malaria [11]. This modification significantly enhances the stability of the kinase and 
apparently could be used for targeting the enzyme to membranes or other specific cellular sites, similar 
to AK1 , another myristoylated 　  adenylate kinase isoform [11,51]. The association of myristoylated 
AK2 with the disease causing clone could be used as a therapeutic target to fight malaria. A large 
specialized network of six adenylate kinase isoforms exists in a unicellular flagellated parasite 
Trypanosoma cruzi, the causative agent of Chagas' disease [59]. This parasite apparently has 
developed a sophisticated phosphotransfer network where adenylate kinase acts in concert with 
arginine kinase and nucleoside diphosphate kinase to support the invasive phenotype [262]. 
Importantly, that mutation in the adenylate kinase gene renders pathogens avirulent [210], suggesting 
new ways to “silence” otherwise deadly bacteria. Also, a nonstructural protein 4B (NS4B) from 
hepatitis C virus, which is absolutely required for viral propagation, was found to possess adenylate 
kinase-like activity [263]. Adenylate kinase 2 is highly upregulated by INF-alpha and IL-15 
stimulation in natural killer (NK) cells suggesting role in innate immune defense [264]. In this regard, 
due to unique catalytic properties and stability adenylate kinase is used as an enzyme amplification 
system in ATP biosensors for detecting bacterial contaminations in food industry, defense and health 
care that improves sensitivity levels up to several thousands fold (Celsis, AKuScreen). A recent study 
demonstrates that mitochondrial AK2 is directly involved in induction of apoptosis through the 
formation of an AK2-FADD-caspase-10 complex and that downregulation of AK2 attenuates 
etoposide- or staurosporine-induced apoptosis in human cells [6]. Significantly, that downregulation of 
cytosolic AK1 transcription with siRNA increases apoptosis in pancreatic cancer cells [265]. Thus, 
adenylate kinase plays a significant role in making decision between life and death in cellular 
existence and could be a target in treatment of infectious disease and cancer.  
In summary, we highlight here new exciting developments regarding multi-faceted adenylate kinase 
biology, revealing the significance of mutations and modifications of this never resting 
phosphotransfer enzyme in energy support of cell motility, disease pathogenesis and regulation of cell 
differentiation and apoptosis.  
8. Summary 
Metabolic signals regulate and integrate many vital functions throughout the human body, including 
energy homeostasis, blood pressure, heart performance, food intake, hormonal status and brain Int. J. Mol. Sci. 2009, 10                 
 
 
1754
performance. Growing evidence indicate the significance of metabolic monitors which directly sense 
cellular energy state and respond to imbalances by generating and delivering signaling molecules to 
metabolic sensors to produce a regulatory response. Adenylate kinase-mediated metabolic monitoring 
and downstream AMP signaling (AK → AMP → AMP-sensors) plays a critical role in the regulation 
of diverse cellular processes and serves as a primary stress-response pathway. Due to signaling to a 
number of AMP/nucleoside-sensitive cellular and extracellular components, adenylate kinase senses 
cellular energetic imbalances caused by physical activity, inadequate oxygenation or nutrient supply, 
generates and transmits feedback signals to adjust cellular energetics, substrate transport and vascular 
blood flow to facilitate oxygen and nutrient delivery. Adenylate kinase phosphotransfer dynamics 
regulates many diverse intracellular and extracellular nucleotide signaling processes, including 
excitation-contraction coupling, hormonal secretion, cell and ciliary motility, nuclear transport, 
energetics of cell cycle, DNA synthesis and break repair, and developmental programming. Moreover, 
adenylate kinase generated and modulated cellular, interstitial and blood AMP levels are emerging as 
potential metabolic signals that are associated with body energy sensing, sleep, hibernation, vascular 
flow and food intake. AMP is a mediator of antidiabetic drug action and has growing importance as a 
therapeutic agent. Within integrated phosphotransfer network, adenylate kinase is essential in 
integration and synchronization of metabolic sensors with the dynamics of cellular metabolism which 
is critical for regulation of genetic, energetic, electrical and signal transduction processes determining 
cell viability and functional activity. As such, adenylate kinase and AMP signaling components 
dispersed throughout the intracellular compartments, extracellular spaces and body fluids comprise a 
major metabolic monitoring and body energy sensing node transducing and distributing signals to 
metabolic sensors, thus conveying information about body energy and fuel usage status. Moreover, 
evidence is mounting regarding the direct relationship between defects in adenylate kinase and AMP 
metabolic signaling and human diseases, such as heart failure, hypertrophic cardiomyopathy, diabetes, 
obesity, hemolytic anemia, reticular dysgenesis, ciliary dyskinesia, cancer and neurodegeneration. 
Thus, adenylate kinase, previously considered as a regular housekeeping enzyme, is a critical player in 
metabolic monitoring and systemic integration of different signaling pathways to ensure cellular 
energy homeostasis and an adequate response to a broad range of functional, environmental and 
stress challenges.  
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